-+ 0.00%
-+ 0.00%
-+ 0.00%
BioRestorative Therapies Delays Q3 Filing as Audits Remain Incomplete
Share
Listen to the news
BioRestorative Therapies Delays Q3 Filing as Audits Remain Incomplete
  • BioRestorative Therapies will miss the filing deadline for its September 30, 2026, Form 10-Q, including the five-day extension.
  • Bush & Associates CPA must complete new audits for 2024 and 2025 before finishing interim financial statement reviews.
  • The June 30, 2026, Form 10-Q also remains unfiled.
  • Results for the three and nine months ended September 30 could differ materially from 2025 amid suspended product sales and advisory expenses.
  • Orders and shipments of biocosmeceutical products were suspended August 7, 2026, pending a business and regulatory review.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioRestorative Therapies Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-120589), on November 16, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending